Effect of Erector Spinae (ESP) Block on Opioid Reduction and Enhanced Recovery After Posterior Cervical Spine Surgery

Launched by UNIVERSITY HEALTH NETWORK, TORONTO · Nov 23, 2020

Keywords

ClinConnect Summary

This clinical trial is studying a method called the Erector Spinae Plane (ESP) block, which aims to help manage pain after patients undergo posterior cervical spine surgery. The goal is to see if this technique can reduce the need for strong pain medications, known as opioids, and support a quicker recovery for patients. Severe pain after surgery can make it hard for patients to move around and heal properly, so finding effective ways to manage that pain is very important.

To participate in the trial, adults aged 18 to 80 who are having specific spine surgeries may be eligible. However, those who are allergic to local anesthetics, are pregnant, or have certain serious health conditions won't be able to take part. Patients in the trial can expect to receive either the ESP block or standard pain management, and their progress will be monitored to see how well they recover. This research could help improve pain management techniques for future patients undergoing similar procedures.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All adult patients aged 18-80 years with ASA class I - III undergoing posterior cervical (C3-T2) decompression and instrumented fusion for cervical stenosis in prone position.
• Exclusion Criteria:
• • 1. In patients who are allergic to local anesthetics.
• • 2. ASA IV patients
• • 3. Lack of informed consent
• • 4. Pregnant patient.
• • 5. Fracture cervical spine
• • 6. Extradural or intradural cervical tumors
• • 7. Surgery of C1 and C2 spine